Envista outlines 2025 guidance with 1-3% core growth and $0.95-$1.05 EPS target
Q4 2024 Management View CEO Paul Keel reported Q4 performance in line with expectations, achieving 2% core growth and a 13.9% adjusted EBITDA margin. The implants business, particularly in North ...
Regional Management signals 10% portfolio growth in 2025 with focus on higher-margin loans
Q4 2024 Management View CEO Rob Beck highlighted strong financial performance in Q4 2024, with net income of $9.9 million and diluted EPS of $0.98, exceeding guidance and showing a significant ...